177 related articles for article (PubMed ID: 9813621)
21. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients.
Evan AP; Bledsoe S; Worcester EM; Coe FL; Lingeman JE; Bergsland KJ
Kidney Int; 2007 Dec; 72(12):1503-11. PubMed ID: 17898697
[TBL] [Abstract][Full Text] [Related]
22. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
Kumar V; Farell G; Lieske JC
J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
[TBL] [Abstract][Full Text] [Related]
23. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
Worcester EM; Nakagawa Y; Coe FL
Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
[TBL] [Abstract][Full Text] [Related]
24. Reduced inhibitory activity of uronic-acid-rich protein in urine of stone formers.
Atmani F; Lacour B; Jungers P; Drüeke T; Daudon M
Urol Res; 1994; 22(4):257-60. PubMed ID: 7871640
[TBL] [Abstract][Full Text] [Related]
25. Alpha-1-microglobulin: inhibitory effect on calcium oxalate crystallization in vitro and decreased urinary concentration in calcium oxalate stone formers.
Tardivel S; Médétognon J; Randoux C; Kébédé M; Drüeke T; Daudon M; Hennequin C; Lacour B
Urol Res; 1999 Aug; 27(4):243-9. PubMed ID: 10460893
[TBL] [Abstract][Full Text] [Related]
26. Uropontin in urinary calcium stone formation.
Hoyer JR
Miner Electrolyte Metab; 1994; 20(6):385-92. PubMed ID: 7783701
[TBL] [Abstract][Full Text] [Related]
27. Inflammation-induced systemic proteolysis of inter-alpha-inhibitor in plasma from patients with sepsis.
Balduyck M; Albani D; Jourdain M; Mizon C; Tournoys A; Drobecq H; Fourrier F; Mizon J
J Lab Clin Med; 2000 Feb; 135(2):188-98. PubMed ID: 10695665
[TBL] [Abstract][Full Text] [Related]
28. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
Ryall RL; Chauvet MC; Grover PK
BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
[TBL] [Abstract][Full Text] [Related]
29. [Glycoprotein inhibitors of urinary calculi formation].
Berland Y; Dussol B
Nephrologie; 1993; 14(4):183-7. PubMed ID: 8232713
[TBL] [Abstract][Full Text] [Related]
30. Identification of myeloperoxidase, alpha-defensin and calgranulin in calcium oxalate renal stones.
Mushtaq S; Siddiqui AA; Naqvi ZA; Rattani A; Talati J; Palmberg C; Shafqat J
Clin Chim Acta; 2007 Sep; 384(1-2):41-7. PubMed ID: 17610860
[TBL] [Abstract][Full Text] [Related]
31. Structure and function of inter-alpha-trypsin inhibitor heavy chains.
Zhuo L; Kimata K
Connect Tissue Res; 2008; 49(5):311-20. PubMed ID: 18991084
[TBL] [Abstract][Full Text] [Related]
32. Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine.
Atmani F; Khan SR
Urol Res; 1995; 23(2):95-101. PubMed ID: 7676539
[TBL] [Abstract][Full Text] [Related]
33. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
Saw NK; Chow K; Rao PN; Kavanagh JP
J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
[TBL] [Abstract][Full Text] [Related]
34. Expression of bikunin mRNA in renal epithelial cells after oxalate exposure.
Iida S; Peck AB; Byer KJ; Khan SR
J Urol; 1999 Oct; 162(4):1480-6. PubMed ID: 10492241
[TBL] [Abstract][Full Text] [Related]
35. Inter-alpha-inhibitor in urine and calcium oxalate urinary crystals.
Dawson CJ; Grover PK; Ryall RL
Br J Urol; 1998 Jan; 81(1):20-6. PubMed ID: 9467471
[TBL] [Abstract][Full Text] [Related]
36. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model].
Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965
[TBL] [Abstract][Full Text] [Related]
37. Proteomic characterization of inter-alpha inhibitor proteins from human plasma.
Josic D; Brown MK; Huang F; Lim YP; Rucevic M; Clifton JG; Hixson DC
Proteomics; 2006 May; 6(9):2874-85. PubMed ID: 16596706
[TBL] [Abstract][Full Text] [Related]
38. Urine protein markers distinguish stone-forming from non-stone-forming relatives of calcium stone formers.
Bergsland KJ; Kelly JK; Coe BJ; Coe FL
Am J Physiol Renal Physiol; 2006 Sep; 291(3):F530-6. PubMed ID: 16622176
[TBL] [Abstract][Full Text] [Related]
39. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
Laube N; Jansen B; Hesse A
Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
[TBL] [Abstract][Full Text] [Related]
40. Inhibitors of oxalocalcic lithiasis: effects of their interactions on calcium oxalate crystallization.
Muñoz JA; López-Mesas M; Valiente M
Urology; 2012 Nov; 80(5):1163.e13-8. PubMed ID: 22748613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
